As of 2025-12-29, the Relative Valuation of Cogent Biosciences Inc (COGT) is (41.36) USD. This relative valuation is based on P/E multiples. With the latest stock price at 38.88 USD, the upside of Cogent Biosciences Inc based on Relative Valuation is -206.4%.
The range of the Relative Valuation is (36.88) - (40.44) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.5x - 24.1x | 21.8x |
| Forward P/E multiples | 22.0x - 32.9x | 27.4x |
| Fair Price | (36.88) - (40.44) | (41.36) |
| Upside | -194.9% - -204.0% | -206.4% |
| Date | P/E |
| 2025-12-26 | -23.15 |
| 2025-12-24 | -23.66 |
| 2025-12-23 | -23.92 |
| 2025-12-22 | -23.42 |
| 2025-12-19 | -23.55 |
| 2025-12-18 | -22.57 |
| 2025-12-17 | -23.49 |
| 2025-12-16 | -23.81 |
| 2025-12-15 | -23.96 |
| 2025-12-12 | -25.07 |
| 2025-12-11 | -23.84 |
| 2025-12-10 | -23.32 |
| 2025-12-09 | -22.94 |
| 2025-12-08 | -24.00 |
| 2025-12-05 | -23.09 |
| 2025-12-04 | -23.41 |
| 2025-12-03 | -23.32 |
| 2025-12-02 | -23.21 |
| 2025-12-01 | -23.67 |
| 2025-11-28 | -23.95 |
| 2025-11-26 | -24.05 |
| 2025-11-25 | -23.65 |
| 2025-11-24 | -22.95 |
| 2025-11-21 | -21.89 |
| 2025-11-20 | -20.66 |
| 2025-11-19 | -20.80 |
| 2025-11-18 | -19.89 |
| 2025-11-17 | -20.10 |
| 2025-11-14 | -19.97 |
| 2025-11-13 | -20.14 |
| 2025-11-12 | -21.00 |
| 2025-11-11 | -19.90 |
| 2025-11-10 | -19.33 |
| 2025-11-07 | -8.82 |
| 2025-11-06 | -8.76 |
| 2025-11-05 | -8.59 |
| 2025-11-04 | -8.41 |
| 2025-11-03 | -9.23 |
| 2025-10-31 | -9.71 |
| 2025-10-30 | -9.65 |
| 2025-10-29 | -9.53 |
| 2025-10-28 | -9.58 |
| 2025-10-27 | -9.65 |
| 2025-10-24 | -9.01 |
| 2025-10-23 | -8.84 |
| 2025-10-22 | -8.84 |
| 2025-10-21 | -9.44 |
| 2025-10-20 | -9.66 |
| 2025-10-17 | -9.76 |
| 2025-10-16 | -9.74 |